Abstract
Objective: To evaluate the cost-effectiveness of the ‘Plants for Joints’ intervention for rheumatoid arthritis (RA) and metabolic syndrome-associated osteoarthritis (MSOA) patients over 16 weeks. Method: Data from two randomized controlled trials were analysed. The first included 77 RA patients (intervention = 40; control = 37) and the second 64 MSOA patients (intervention = 32; control = 32). The intervention comprised a 16 week lifestyle programme including a whole-food plant-based diet, exercise, and stress management; control participants received usual care. Data from both trials were analysed together and separately. Costs were measured from societal and healthcare perspectives. Effects were expressed in quality-adjusted life-years (QALYs). Results: The intervention cost €886/patient. Intervention group participants gained more QALYs than the control group (0.009; 95% confidence interval −0.004 to 0.023), equivalent to 3.3 additional days in ‘perfect health’ (0.009 × 365). Healthcare costs were higher in the intervention group, while societal costs were lower. None of these differences was statistically significant. From a societal perspective, the intervention had a moderate to high probability of being cost-effective compared with usual care, while the probability was low from a healthcare perspective. Stratified analyses indicated that the probability of cost-effectiveness was higher in RA than in MSOA patients. This difference became less pronounced after excluding outliers. Conclusion: The Plants for Joints intervention demonstrated a relatively high probability of cost-effectiveness from a societal perspective, although this was lower from a healthcare perspective. If these benefits are sustained in the long term, this intervention may reduce the disease and economic burden of arthritic conditions.
Cite
CITATION STYLE
van Dongen, J. M., Bernaers, L., Wagenaar, C. A., van der Leeden, M., Turkstra, F., Boers, M., … Walrabenstein, W. (2026). A multidisciplinary lifestyle programme for patients with rheumatoid arthritis and metabolic syndrome-associated osteoarthritis: economic evaluation alongside the ‘Plants for Joints’ randomized controlled trials. Scandinavian Journal of Rheumatology, 55(1), 21–31. https://doi.org/10.1080/03009742.2025.2550133
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.